Species differences in carcinogen metabolism and interspecies extrapolation

Area of Science:

• Toxicology
• Metabolic Biochemistry
• Carcinogenesis Research

Background:

• Carcinogen activity often varies between species, suggesting a role for metabolic processes.
• Metabolic activation to reactive electrophiles is a key step in the tumorigenic effects of many carcinogens.

Purpose of the Study:

• To explore the role of metabolic differences in species-specific carcinogenicity.
• To investigate how dose and metabolic saturation affect carcinogen extrapolation from animals to humans.
• To highlight the impact of interindividual metabolic variation on human cancer risk.

Main Methods:

• Review of existing literature on species differences in carcinogen metabolism.
• Analysis of how metabolic pathways (activation and detoxication) contribute to varying carcinogenicity.
• Discussion of physiologically based kinetic modeling for improved dose extrapolation.
• Examination of genetic polymorphisms in metabolizing enzymes.

Main Results:

• Metabolic differences, both quantitative and qualitative, are a primary driver of species variation in carcinogenicity.
• High-dose studies may not accurately reflect low-dose human exposures due to metabolic saturation.
• Physiologically based kinetic modeling offers more realistic interspecies dose scaling than traditional methods.
• Human carcinogen metabolism exhibits significant interindividual variability, influenced by genetic polymorphisms.

Conclusions:

• Metabolic differences are a key factor in species-specific carcinogen activity.
• Accurate extrapolation of animal carcinogenicity data to humans requires consideration of metabolic differences and dose.
• Individual genetic variations in carcinogen metabolism can lead to differential cancer risks within the human population.